Overview

A Study of Andexanet Alfa in Patients Requiring Urgent Surgery or Procedure

Status:
WITHDRAWN
Trial end date:
2027-09-07
Target enrollment:
Participant gender:
Summary
The study will aim to find out if the drug andexanet alfa is safe and effective in preventing major bleeding during urgent surgery or invasive procedures. The study will compare the use of andexanet alfa to the usual care given at the study center.
Phase:
PHASE3
Details
Lead Sponsor:
AstraZeneca
Treatments:
PRT064445